Newsroom
Market News
Both sides of the trade, grades and news round-ups. Click a headline to read it — the arrows walk the list.
Research
- Tesla Cybertruck Explosion and Stock News Update
- Global Stock News Roundup January 7, 2025
- Investors Alerted to Class Action Against Marqeta, Inc. (MQ)
- Companies to Present at 43rd Annual J.P. Morgan Healthcare Conference
- Meta Shifts Content Moderation to Users: Market Reaction and Industry Response
- Nvidia Stock News Update: Nasdaq Dips, Huang Discusses AI Chips and Autonomous Vehicles
- Getty Images & Shutterstock Merger Sparks Investor Interest
- AstraZeneca's Pipeline Undervalued and Facing Legal Action Over Securities Fraud Allegations
- Capri Holdings Limited Investors Urged to Take Action Before February 21, 2025
- Meta Moves Moderators to Texas to Combat Bias Concerns
- Marqeta Inc. Faces Class Action Lawsuit from Investors
- Exciting Biotech Companies to Present at J.P. Morgan Healthcare Conference
- Tesla 2024 Year In Review: Stock Downgrades, Investigations, and Future Prospects
- Key Points:
- Investors Alerted to Class Action Lawsuit Against PACS Group, Inc. (PACS)
- Top AI Stocks: AVGO, NVDA, AEYE, and FIVN Trends and Insights
- SOLUSD Recent News Highlights
- ADAUSD Recent News Highlights
- XRPUSD Recent News Highlights
- ETHUSD Recent News Highlights
- BTCUSD Recent News Highlights
- Google's Quantum Chip Breakthrough Boosts Stock 12% in January
- Positive Analyst Upgrades Propel American Airlines Stock Higher
- Key Points:
- Chipotle Mexican Grill Securities Lawsuit Update
- Deadline Approaching for TMC Shareholders with Losses to Seek Counsel
- Record Online Holiday Spending Reaches $1.2 Trillion, Salesforce Report Shows
- Quantum Computing Stocks Soar as AI, Quantum, And Robotics Take Center Stage
- MGP Ingredients, Inc. Lawsuit - Shareholders Reminded of Lead Plaintiff Deadline
- Shareholders Urged to Take Action by January 21, 2025 in Xerox Holdings Corporation Lawsuit
- Legal Troubles Plague Warner Bros. Discovery, Inc. as Shareholders Seek Redress
- Investors Alert: Investigation Launched into BioAge Labs, Inc. (BIOA)
- Warren Buffett's Success in 2024 and S&P 500 Performance Comparison
- Cassava Sciences, Inc. Faces Securities Law Violations Lawsuits
- Revance Therapeutics, Inc. Investors Alerted to Securities Fraud Class Action Lawsuits
- Lucid Motors Stock Surges on Record Quarterly Deliveries
- Microsoft Outpaces Stock Market with AI Investments and Partnerships
- Securities Class Action Lawsuit Alert for Joint Stock Company Kaspi.kz Investors
- Gold Prices Dip Despite Analysts Remaining Positive
- Lawsuits Filed Against Caribou Biosciences, Inc. Lead to Class Action Deadline
Ask the market a question. Get a calculated answer.
The AI is not a chatbot bolted onto a document store. It calls the same analytics engine that powers every screen on this platform — so what comes back is a number it computed from raw history, with the command that produced it.
86,000+ instruments
Global equities, ETFs, funds, options, FX, commodities, crypto, economics, filings, transcripts and news — one normalised symbol universe with adjusted history.
A real analytics engine
Screening, backtesting, technicals, options analytics, correlations, seasonality and factor models — computed on demand from raw prices, never a stale cache.
It shows its working
Answers arrive with the charts, tables and tool calls behind them, so you can check the number instead of trusting a paraphrase.
Your own documents
Upload filings, decks and research. Ask across them and the answer cites the page it came from.
Agents and workflows
Multi-step research that runs the platform's tools for you — screen, pull the history, compute, compare, then write it up.
MCP, CLI and API
The same command catalogue from Claude, your own agent, a shell or your pipeline. The answer on screen is the answer your job gets at 4am.
You ask
“How does NVDA usually trade through earnings?”
It calls
→ ka.options_expected_move(NVDA)
It answers
NVDA has averaged a 9.2% absolute move on the day after earnings and closed higher 67% of the time. Two in three reactions land between −4.2% and +16.3% — the distribution is skewed right, not symmetric.
Every figure computed live from our own history — not scraped, not summarised.
Or start with